EPO and depressive disorder: Indeed, they reported that HIF-1 may produce beneficial effects on depression, as it targets genes that have been shown to elicit antidepressant effects in animal models (erythropoietin (EPO) and vascular endothelial growth factor (VEGF) genes (Li et al., 2020).